FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912944072> ?p ?o ?g. }

• W2912944072 endingPage "1951" @default.
• W2912944072 startingPage "1945" @default.
• W2912944072 abstract "Many inflammatory bowel disease (IBD) patients do not respond to medical therapy. Tofacitinib is a first-in-class, partially selective inhibitor of Janus kinase, recently approved for treating patients with ulcerative colitis (UC). We describe our experience with the use of tofacitinib for treatment of patients with moderate-to-severe IBD.This is a retrospective, observational study of the use of tofacitinib in IBD. Patients with medically resistant IBD were treated orally with 5 mg or 10 mg twice daily. Clinical response and adverse events were assessed at 8, 26, and 52 weeks. Objective response was assessed endoscopically, radiologically, and biochemically.58 patients (53 UC, 4 Crohn's, 1 pouchitis) completed at least 8 weeks of treatment with tofacitinib. 93% of the patients previously failed treatment with anti-TNF. At 8 weeks of treatment, 21 patients (36%) achieved a clinical response, and 19 (33%) achieved clinical remission. Steroid-free remission at 8 weeks was achieved in 15 patients (26%). Of the 48 patients followed for 26 weeks, 21% had clinical, steroid-free remission. Of the 26 patients followed for 12 months, 27% were in clinical, steroid-free remission. Twelve episodes of systemic infections were noted, mostly while on concomitant steroids. One episode of herpes zoster infection was noted during follow-up.In this cohort of patients with moderate-to-severe, anti-TNF resistant IBD, tofacitinib induced clinical response in 69% of the patients. 27% were in clinical, steroid-free remission by 1 year of treatment. Tofacitinib is an effective therapeutic option for this challenging patient population." @default.
• W2912944072 created "2019-02-21" @default.
• W2912944072 creator A5044542949 @default.
• W2912944072 creator A5049169459 @default.
• W2912944072 creator A5059142660 @default.
• W2912944072 creator A5061920772 @default.
• W2912944072 creator A5063018115 @default.
• W2912944072 creator A5083147613 @default.
• W2912944072 creator A5087761009 @default.
• W2912944072 creator A5089162628 @default.
• W2912944072 creator A5090724885 @default.
• W2912944072 creator A5091195989 @default.
• W2912944072 date "2019-02-07" @default.
• W2912944072 modified "2023-10-01" @default.
• W2912944072 title "Real-World Experience with Tofacitinib in IBD at a Tertiary Center" @default.
• W2912944072 cites W1881640566 @default.
• W2912944072 cites W1921689204 @default.
• W2912944072 cites W2004608617 @default.
• W2912944072 cites W2009025779 @default.
• W2912944072 cites W2092863985 @default.
• W2912944072 cites W2162805528 @default.
• W2912944072 cites W2163184895 @default.
• W2912944072 cites W2413887177 @default.
• W2912944072 cites W2533384923 @default.
• W2912944072 cites W2539630895 @default.
• W2912944072 cites W2561041192 @default.
• W2912944072 cites W2583548739 @default.
• W2912944072 cites W2587875644 @default.
• W2912944072 cites W2611548364 @default.
• W2912944072 cites W2623221337 @default.
• W2912944072 cites W2673376286 @default.
• W2912944072 cites W2807009918 @default.
• W2912944072 doi "https://doi.org/10.1007/s10620-019-05492-y" @default.
• W2912944072 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6935176" @default.
• W2912944072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30734234" @default.
• W2912944072 hasPublicationYear "2019" @default.
• W2912944072 type Work @default.
• W2912944072 sameAs 2912944072 @default.
• W2912944072 citedByCount "74" @default.
• W2912944072 countsByYear W29129440722019 @default.
• W2912944072 countsByYear W29129440722020 @default.
• W2912944072 countsByYear W29129440722021 @default.
• W2912944072 countsByYear W29129440722022 @default.
• W2912944072 countsByYear W29129440722023 @default.
• W2912944072 crossrefType "journal-article" @default.
• W2912944072 hasAuthorship W2912944072A5044542949 @default.
• W2912944072 hasAuthorship W2912944072A5049169459 @default.
• W2912944072 hasAuthorship W2912944072A5059142660 @default.
• W2912944072 hasAuthorship W2912944072A5061920772 @default.
• W2912944072 hasAuthorship W2912944072A5063018115 @default.
• W2912944072 hasAuthorship W2912944072A5083147613 @default.
• W2912944072 hasAuthorship W2912944072A5087761009 @default.
• W2912944072 hasAuthorship W2912944072A5089162628 @default.
• W2912944072 hasAuthorship W2912944072A5090724885 @default.
• W2912944072 hasAuthorship W2912944072A5091195989 @default.
• W2912944072 hasBestOaLocation W29129440722 @default.
• W2912944072 hasConcept C126322002 @default.
• W2912944072 hasConcept C141071460 @default.
• W2912944072 hasConcept C197934379 @default.
• W2912944072 hasConcept C2776233030 @default.
• W2912944072 hasConcept C2777575956 @default.
• W2912944072 hasConcept C2778260677 @default.
• W2912944072 hasConcept C2778886723 @default.
• W2912944072 hasConcept C2779134260 @default.
• W2912944072 hasConcept C2779384505 @default.
• W2912944072 hasConcept C2779454807 @default.
• W2912944072 hasConcept C2780479503 @default.
• W2912944072 hasConcept C41260117 @default.
• W2912944072 hasConcept C71924100 @default.
• W2912944072 hasConcept C90924648 @default.
• W2912944072 hasConceptScore W2912944072C126322002 @default.
• W2912944072 hasConceptScore W2912944072C141071460 @default.
• W2912944072 hasConceptScore W2912944072C197934379 @default.
• W2912944072 hasConceptScore W2912944072C2776233030 @default.
• W2912944072 hasConceptScore W2912944072C2777575956 @default.
• W2912944072 hasConceptScore W2912944072C2778260677 @default.
• W2912944072 hasConceptScore W2912944072C2778886723 @default.
• W2912944072 hasConceptScore W2912944072C2779134260 @default.
• W2912944072 hasConceptScore W2912944072C2779384505 @default.
• W2912944072 hasConceptScore W2912944072C2779454807 @default.
• W2912944072 hasConceptScore W2912944072C2780479503 @default.
• W2912944072 hasConceptScore W2912944072C41260117 @default.
• W2912944072 hasConceptScore W2912944072C71924100 @default.
• W2912944072 hasConceptScore W2912944072C90924648 @default.
• W2912944072 hasIssue "7" @default.
• W2912944072 hasLocation W29129440721 @default.
• W2912944072 hasLocation W29129440722 @default.
• W2912944072 hasLocation W29129440723 @default.
• W2912944072 hasLocation W29129440724 @default.
• W2912944072 hasOpenAccess W2912944072 @default.
• W2912944072 hasPrimaryLocation W29129440721 @default.
• W2912944072 hasRelatedWork W1998231725 @default.
• W2912944072 hasRelatedWork W2105447106 @default.
• W2912944072 hasRelatedWork W2108275251 @default.
• W2912944072 hasRelatedWork W2156836353 @default.
• W2912944072 hasRelatedWork W2416299497 @default.
• W2912944072 hasRelatedWork W2800521242 @default.
• W2912944072 hasRelatedWork W2911490286 @default.

• next